ABSTRACT
BACKGROUND: Dyspnea secondary to acute upper airways airflow limitation (UAAFL) represents a clinical emergency that can be difficult to recognize without a suitable history; even when etiology is known, parameters to assess the severity are unclear and often improperly used. OBJECTIVES: The aim of this study was to assess the role of peripheral oxygen saturation (SpO2) as a predictor of severity of upper airway obstruction. METHODS: The authors propose an experimental model of upper airway obstruction by a progressive increase of UAAFL. Ten healthy volunteers randomly underwent ventilation for 6 min with different degrees of UAAFL. SpO2, heart rate, respiratory rate (RR), tidal volume, accessory respiratory muscle activation, and subjective dyspnea indexes were measured. RESULTS: In this model, SpO2 was not reliable as the untimely gravity index of UAAFL. Respiratory rate, visual analogue scale (VAS), and Borg dyspnea scale were statistically correlated with UAAFL (p < 0.0001 for RR and p < 0.05 for VAS and Borg scale). No significant changes were observed on heart rate (p > 0.05) and tidal volume (p > 0.05); a RR ≤ 7 breaths/min; VAS and Borg scale showed statistically significant parameters changes (p < 0.05). CONCLUSIONS: RR, VAS, and Borg dyspnea scales are sensitive parameters to detect and stage, easily and quickly, the gravity of an upper airways impairment, and should be used in emergency settings for an early diagnosis of a UAAFL. SpO2 is a poorer predictor of the degree of upper airways flow limitation.
Subject(s)
Airway Obstruction/complications , Airway Obstruction/diagnosis , Dyspnea/etiology , Oxygen/blood , Adult , Airway Obstruction/physiopathology , Dyspnea/physiopathology , Female , Healthy Volunteers , Humans , Male , Predictive Value of TestsABSTRACT
PURPOSE: To present the clinical features of patients with parotid gland metastasis, and compare the results with previously published series. Most of the relevant literature arises from case reports, while there are only few series reported, as secondary neoplastic lesions of the parotid gland are uncommon. METHODS: The medical records of patients with parotid gland metastasis, treated at the ENT Department of the University Hospital of Ferrara, between January 1st 1965 and December 31th 2014, were retrospectively reviewed. Fine needle aspiration cytology (FNAC) and biopsy results were compared. Localization of the primary tumor was searched in all cases. Lymphomatous lesions have been excluded from the study. RESULTS: A total of 66 patients with parotid gland metastasis were evaluated. There were 53 males and 13 females with mean age 68.2 ± 13.5 years. Histopathologic analysis of the lesions revealed that 47 (71.2%) were parotid gland metastasis from cutaneous head and neck tumors, 8 (12.1%) from the upper aero-digestive tract, 7 (12.1%) from locations out of facial-cervical region, 1 from a conjunctival melanoma, while in 3 (4.5%) cases the primary tumor origin remained unknown. FNAC results were compared with the final histopathologic diagnosis, showing an overall concordance of 71.9%. CONCLUSION: The present study is one of the largest series of parotid gland metastasis available so far. During the diagnostic work-up of a parotid tumor, the possibility of a metastasis should also be considered. FNAC can be a useful tool for the preoperative assessment of parotid lesions.